During this presentation of the Cancer Moonshot Seminar Series, Carl June, M.D. (University of Pennsylvania) discusses updates in chimeric antigen receptor (CAR) T cell therapies and his Immuno-Oncology Translational Network (IOTN) research. This work is related to the Blue Ribbon Panel recommendation to create an adult immunotherapy network.

https://www.cancer.gov/research/key-i...